Method and apparatus for utilizing amplitude-modulated pulse-width modulation signals for neurostimulation and treatment of neurological disorders using electrical stimulation

• US 7,715,910 B2
• Filed: 07/21/2006
• Issued: 05/11/2010
• Est. Priority Date: 02/04/2002
• Status: Expired due to Fees

• Current Assignee: Jeffrey B. Hargrove
• Original Assignee: Cerephex Corporation
• Inventors: Esty, Mary L., Hargrove, Jeffrey B., Stokes, Theodore J.
• Primary Examiner(s): Hindenburg; Max
• Assistant Examiner(s): SMITH, FANGEMONIQUE A
• Application Number:
  US11/490,255
• Publication Number:
  US 20060258950A1
• Time in Patent Office: 1,390 Days
• Field of Search: 600/544, 600/373, 600/27, 600/301, 607/45, 607/100, 607/3, 607/60
• US Class Current: 600/544
• CPC Class Codes: A61B 5/374 Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
• CPC Class Codes: A61B 5/4076 Diagnosing or monitoring particular conditions of the nervous system A61B5/4821, A61B5/4824 take precedence
• CPC Class Codes: A61N 1/36021 for treatment of pain
• CPC Class Codes: A61N 1/36025 for treating a mental or cerebral condition

Abstract

A computing device-controlled system is described for the generation of amplitude-modulated pulse-width modulation (AMPWM) signals for use in treating neurological dysfunction via cranial neurostimulation, where the AMPWM signal is specifically designed to minimize the electrical impedance of the tissues of the head. A low-frequency carrier signal is determined for the AMPWM signal by measuring EEG activity at a reference site or sites, generally corresponding with the location of suspected brain dysfunction. Carrier signal frequency is variably related to critical frequency components of the EEG power spectral density, determined from statistical analysis of amplitudes and variability, and dynamically changed as a function of time to prevent entrainment. The AMPWM signal is presented to a subject via a plurality of neurostimulation delivery modes for therapeutic use.

Claims

1. A method for providing external electrical stimulation and treatment for a disorder by electrically stimulating and treating neurological tissue of a region of a brain, the method comprising:

generating an amplitude-modulated pulse-width modulation (AMPWM) signal, the AMPWM signal including a high frequency signal component and a low frequency signal component, wherein the high frequency signal component is amplitude-modulated and pulse-width modulated, wherein the high frequency signal component has a sufficiently high frequency to enable the AMPWM signal to penetrate high impedance portions of tissue located between external EEG sensors placed on a scalp and the neurological tissue of the region of the brain being stimulated, wherein the low frequency signal component is of sufficiently low frequency to provide the electrical stimulation and treatment; and

transmitting the AMPWM signal from a neurostimulation device to the neurological tissue of the region of the brain being stimulated via the external EEG sensors placed on the scalp.

2. The method of claim 1, wherein the neurostimulation device and EEG sensors are externally located relative to the tissue and the neurological tissue of the region of the brain.

3. The method of claim 1, further comprising:

measuring a voltage associated with electrical activity at least one reference site of the scalp.

4. The method of claim 3, wherein generating the AMPWM signal occurs after determining a measured voltage.

5. The method of claim 3, wherein the AMPWM signal is induced into an EEG lead to provide the electrical stimulation and treatment at an overlapping time period with a measured voltage.

6. The method of claim 5, wherein the high frequency signal component of the AMPWM signal includes periodic times having minimal amplitude, and wherein measuring the voltage occurs during the periodic times having minimal amplitude.

7. The method of claim 6, wherein the measured voltage comprises an EEG signal.

8. The method of claim 1, wherein the low frequency signal component dynamically varies in frequency over time.

9. The method of claim 1, wherein the disorder to be treated is a neurological disorder.

10. The method of claim 9, wherein the neurological disorder is not a specific neurological event.

11. The method of claim 1, wherein the high frequency signal component is in the range of 43 hertz to 1,000,000 hertz and the low frequency signal component is in the range of 1 hertz-43 hertz.

12. The method of claim 11, wherein the high frequency signal component is in the range of 1,000 hertz-100,000 hertz.

13. The method of claim 11, wherein the high frequency signal component is in the range of 10,000 hertz-20,000 hertz.

14. The method of claim 1, wherein the high frequency signal component is pulse-width modulated so as to control a time-averaged current of the electrical stimulation signal when passing through a conducting medium, wherein the conducting medium comprises the tissue located between the external EEG sensors placed on the scalp and the neurological tissue of the region of the brain being stimulated.

15. A method for providing external electrical stimulation and treatment for a disorder by electrically stimulating and treating neurological tissue of a region of a brain, the method comprising:

determining a voltage at least one reference site on a scalp;

generating an amplitude-modulated pulse-width modulation (AMPWM) signal, the AMPWM signal including a high frequency signal component and a low frequency signal component, wherein the high frequency signal is amplitude-modulated and pulse-width modulated, wherein the high frequency signal component has a sufficiently high frequency to enable the AMPWM signal to penetrate high impedance portions of the tissue located between the external EEG sensors on the scalp and the neurological tissue of the region of the brain, wherein the low frequency signal component is of sufficiently low frequency to provide the electrical stimulation and treatment, and wherein the low frequency signal component dynamically varies in frequency over time;

generating an electrical stimulation and treatment signal from the AMPWM signal;

applying an electrical signal with characteristics to minimize signal attenuation due to the impedance of the tissue located between the external EEG sensors on the scalp and the neurological tissue of the region of the brain being stimulated; and

transmitting the electrical stimulation and treatment signal to the neurological tissue of the region of the brain being stimulated via the external EEG sensors placed on the scalp.

16. The method of claim 15, wherein the electrical stimulation is provided by a neurostimulation device located externally relative to the tissue located between the external EEG sensors placed on the scalp and the neurological tissue of the region of the brain.

17. The method of claim 15, wherein the electrical signal is an amplitude-modulated pulse-width modulation (AMPWM) signal.

18. The method of claim 15, wherein the disorder to be treated is a neurological disorder.

19. The method of claim 15, wherein the electrical stimulation and treatment signal includes an external stimulation signal that drives an external stimulation device.

20. The method of claim 19, wherein the external stimulation device is an audio stimulation device.

21. The method of claim 19, wherein the external stimulation device is an optic stimulation device.